Stemtech Corporation (OTCPK:STEK) entered into a letter of intent to acquire Life Factor Research on August 29, 2022. As of October 25, 2022, Stemtech Corporation entered into a definitive agreement to acquire Life Factor Research. Life Factor Research will act as the division responsible for research and development and product formulations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0481 USD | -3.80% | -17.78% | +48.00% |
1st Jan change | Capi. | |
---|---|---|
+48.00% | 5.62M | |
-0.07% | 91.42B | |
+2.76% | 41.08B | |
-9.06% | 34.26B | |
+55.32% | 25.27B | |
-16.61% | 15.27B | |
-9.14% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+7.79% | 9.16B |
- Stock Market
- Equities
- STEK Stock
- News Stemtech Corporation
- Stemtech Corporation entered into a letter of intent to acquire Life Factor Research.